Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies.
Kieseier
Bernd C
BC
Department of Neurology, Heinrich-Heine-University Moorenstrasse 5, 40225 Düsseldorf, Germany.
Hartung
Hans-Peter
HP
D000818:Animals; D001284:Atrophy / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D001921:Brain / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D004195:Disease Models, Animal; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology* / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods / Q000639:trends; D016899:Interferon-beta / Q000494:pharmacology* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014855:Wallerian Degeneration / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology
D007155:Immunologic Factors; D018696:Neuroprotective Agents; D016899:Interferon-beta